<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>Chapter 4 Method for drug-repurpusing | Network Medicine</title>
  <meta name="description" content="Workshop in Advanced Bioinformatics: Network Medicine." />
  <meta name="generator" content="bookdown 0.21 and GitBook 2.6.7" />

  <meta property="og:title" content="Chapter 4 Method for drug-repurpusing | Network Medicine" />
  <meta property="og:type" content="book" />
  
  
  <meta property="og:description" content="Workshop in Advanced Bioinformatics: Network Medicine." />
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Chapter 4 Method for drug-repurpusing | Network Medicine" />
  
  <meta name="twitter:description" content="Workshop in Advanced Bioinformatics: Network Medicine." />
  

<meta name="author" content="Deisy Morselli Gysi" />


<meta name="date" content="2021-02-04" />

  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="methods.html"/>
<link rel="next" href="summary.html"/>
<script src="libs/header-attrs-2.6.6/header-attrs.js"></script>
<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />









<script src="libs/kePrint-0.0.1/kePrint.js"></script>
<link href="libs/lightable-0.0.1/lightable.css" rel="stylesheet" />


<style type="text/css">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">Network Medicine</a></li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> Workshop in Advanced Bioinformatics: Network Medicine.</a>
<ul>
<li class="chapter" data-level="1.1" data-path="index.html"><a href="index.html#whatarenets"><i class="fa fa-check"></i><b>1.1</b> What are networks?</a></li>
<li class="chapter" data-level="1.2" data-path="index.html"><a href="index.html#terminology"><i class="fa fa-check"></i><b>1.2</b> Terminology</a>
<ul>
<li class="chapter" data-level="1.2.1" data-path="index.html"><a href="index.html#network-terminology"><i class="fa fa-check"></i><b>1.2.1</b> Network Terminology</a></li>
<li class="chapter" data-level="1.2.2" data-path="index.html"><a href="index.html#biological-terminology"><i class="fa fa-check"></i><b>1.2.2</b> Biological Terminology</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="2" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html"><i class="fa fa-check"></i><b>2</b> Data Commonly Used in Network Medicine</a>
<ul>
<li class="chapter" data-level="2.1" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#PPI"><i class="fa fa-check"></i><b>2.1</b> Protein-Protein Interaction Networks</a>
<ul>
<li class="chapter" data-level="2.1.1" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#measuring-ppis"><i class="fa fa-check"></i><b>2.1.1</b> Measuring PPIs</a></li>
<li class="chapter" data-level="2.1.2" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#commonly-used-data-sources-for-ppis"><i class="fa fa-check"></i><b>2.1.2</b> Commonly used data sources for PPIs</a></li>
<li class="chapter" data-level="2.1.3" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#understanding-a-ppi"><i class="fa fa-check"></i><b>2.1.3</b> Understanding a PPI</a></li>
<li class="chapter" data-level="2.1.4" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#exercises"><i class="fa fa-check"></i><b>2.1.4</b> Exercises</a></li>
</ul></li>
<li class="chapter" data-level="2.2" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#GDA"><i class="fa fa-check"></i><b>2.2</b> Gene Disease Association</a>
<ul>
<li class="chapter" data-level="2.2.1" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#commonly-used-data-sources-for-gdas"><i class="fa fa-check"></i><b>2.2.1</b> Commonly used data sources for GDAs</a></li>
<li class="chapter" data-level="2.2.2" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#understanding-a-gda-dataset"><i class="fa fa-check"></i><b>2.2.2</b> Understanding a GDA dataset</a></li>
<li class="chapter" data-level="2.2.3" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#exercises-1"><i class="fa fa-check"></i><b>2.2.3</b> Exercises</a></li>
</ul></li>
<li class="chapter" data-level="2.3" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#DTs"><i class="fa fa-check"></i><b>2.3</b> Drug-Targets</a>
<ul>
<li class="chapter" data-level="2.3.1" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#properties-of-an-ideal-drug-target"><i class="fa fa-check"></i><b>2.3.1</b> Properties of an ideal drug target:</a></li>
<li class="chapter" data-level="2.3.2" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#commonly-used-data-sources-for-gdas-1"><i class="fa fa-check"></i><b>2.3.2</b> Commonly used data sources for GDAs</a></li>
<li class="chapter" data-level="2.3.3" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#understanding-a-drug-target-dataset"><i class="fa fa-check"></i><b>2.3.3</b> Understanding a Drug-Target dataset</a></li>
<li class="chapter" data-level="2.3.4" data-path="data-commonly-used-in-network-medicine.html"><a href="data-commonly-used-in-network-medicine.html#exercises-2"><i class="fa fa-check"></i><b>2.3.4</b> Exercises</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="3" data-path="methods.html"><a href="methods.html"><i class="fa fa-check"></i><b>3</b> Methods for Disease Module Identification and Disease Similarity</a>
<ul>
<li class="chapter" data-level="3.1" data-path="methods.html"><a href="methods.html#diseasemodule"><i class="fa fa-check"></i><b>3.1</b> Disease Module</a>
<ul>
<li class="chapter" data-level="3.1.1" data-path="methods.html"><a href="methods.html#largest-connected-component"><i class="fa fa-check"></i><b>3.1.1</b> Largest connected component</a></li>
<li class="chapter" data-level="3.1.2" data-path="methods.html"><a href="methods.html#example-in-real-data"><i class="fa fa-check"></i><b>3.1.2</b> Example in real data</a></li>
<li class="chapter" data-level="3.1.3" data-path="methods.html"><a href="methods.html#exercises-3"><i class="fa fa-check"></i><b>3.1.3</b> Exercises</a></li>
</ul></li>
<li class="chapter" data-level="3.2" data-path="methods.html"><a href="methods.html#gene-overlap"><i class="fa fa-check"></i><b>3.2</b> Gene Overlap</a></li>
<li class="chapter" data-level="3.3" data-path="methods.html"><a href="methods.html#dissep"><i class="fa fa-check"></i><b>3.3</b> Disease Separation</a>
<ul>
<li class="chapter" data-level="3.3.1" data-path="methods.html"><a href="methods.html#example-in-real-data-1"><i class="fa fa-check"></i><b>3.3.1</b> Example in real data</a></li>
</ul></li>
<li class="chapter" data-level="3.4" data-path="methods.html"><a href="methods.html#exercises-4"><i class="fa fa-check"></i><b>3.4</b> Exercises</a></li>
</ul></li>
<li class="chapter" data-level="4" data-path="method-for-drug-repurpusing.html"><a href="method-for-drug-repurpusing.html"><i class="fa fa-check"></i><b>4</b> Method for drug-repurpusing</a>
<ul>
<li class="chapter" data-level="4.1" data-path="method-for-drug-repurpusing.html"><a href="method-for-drug-repurpusing.html#proximity"><i class="fa fa-check"></i><b>4.1</b> Proximity</a></li>
<li class="chapter" data-level="4.2" data-path="method-for-drug-repurpusing.html"><a href="method-for-drug-repurpusing.html#example-in-real-data-2"><i class="fa fa-check"></i><b>4.2</b> Example in real data</a></li>
<li class="chapter" data-level="4.3" data-path="method-for-drug-repurpusing.html"><a href="method-for-drug-repurpusing.html#exercises-5"><i class="fa fa-check"></i><b>4.3</b> Exercises</a></li>
</ul></li>
<li class="chapter" data-level="5" data-path="summary.html"><a href="summary.html"><i class="fa fa-check"></i><b>5</b> Summary</a></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="./">Workshop in Advanced Bioinformatics</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Network Medicine</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="method-for-drug-repurpusing" class="section level1" number="4">
<h1><span class="header-section-number">Chapter 4</span> Method for drug-repurpusing</h1>
<p>In this Chapter, we will learn how to calculate the proximity of a drug to a disease - and infer drug repurpusing (Session <a href="method-for-drug-repurpusing.html#proximity">4.1</a>)- based on network methodologies.</p>
<p>There are different methods that are used for drug-repurpusing based on networks, such as the <strong>diffusion state distance (DSD)</strong> <span class="citation">(<a href="references.html#ref-Cao2013" role="doc-biblioref">Cao et al. 2013</a>)</span>, that uses a <strong>graph diffusion property</strong> to derive a similarity metric for pairs of nodes, it takes into account how their similarly affect the rest of the network; and <strong>AI-based methods</strong>, where a heterogeneous graph <span class="math inline">\(G = (V,R)\)</span> with N nodes <span class="math inline">\(v_i \in V\)</span> representing distinct types of biomedical entities and labeled edges representing semantically distinct types of edges between the entities (i.e., protein-protein interactions, drug-target associations, disease-protein associations, and drug-disease indications) and are tasked to predict drugs for a particular disease <span class="citation">(<a href="references.html#ref-Zitnik2018" role="doc-biblioref">Zitnik, Agrawal, and Leskovec 2018</a>)</span>. Due to the limited time, we will focus only on the proximity-based method.</p>
<p>For this, we will be using the <code>R</code> package <code>NetSci</code> and to make the appropriate visualizations we will use <code>igraph</code>.</p>
<div id="proximity" class="section level2" number="4.1">
<h2><span class="header-section-number">4.1</span> Proximity</h2>
<p>Given G, the set of Disease-Genes, T, the set of drug targets, and d(g,t), the shortest path length between nodes <span class="math inline">\(g \in G\)</span> and <span class="math inline">\(t \in T\)</span> in the network, the proximity can be defined as <span class="citation">(<a href="references.html#ref-Guney2016" role="doc-biblioref">Guney et al. 2016</a>)</span>:</p>
<p><span class="math display">\[ 
d(g,t)  = \frac{1}{|\left|T\right||}\sum_{t\in T}\underset{v\in V}\min{d(g,t)}.
\]</span></p>
<p>A visual representation of the method can be seen in Figure <a href="method-for-drug-repurpusing.html#fig:proximity">4.1</a>.</p>
<p>The proximity for drug 2 to the disease is calculated by the average of the shortest path from its targets to the disease genes. The shortest path from N to D is 1, from F to D is 3, the average is 2.</p>
<p>For Drug 1, we have:
<span class="math display">\[d(Drug_1, disease) = \frac{2 + 2 + 1}{3} = 1.66.\]</span></p>
<div class="figure"><span id="fig:proximity"></span>
<img src="NetMed_files/figure-html/proximity-1.png" alt="Drug-Target &amp; Disease-Module Proximity. Triangles represent Disease Associated Genes, while circles represent non-associated genes. In dark purple, we see the drugs and light purple, its targets." width="672" />
<p class="caption">
Figure 4.1: Drug-Target &amp; Disease-Module Proximity. Triangles represent Disease Associated Genes, while circles represent non-associated genes. In dark purple, we see the drugs and light purple, its targets.
</p>
</div>
<p>Similarly to the LCC (Session <a href="methods.html#diseasemodule">3.1</a>) it is important to calculate a measure of randomness associate to the proximity. In the same sense, it is important that the nodes being randomized, the nodes are not simply randomly selected from the pool of proteins in the PPI, but rather selected from matching degree proteins. To calculate the significance of the proximity one can calculate its Z-Score or simply calculate the empirical probability under the curve from the empirical distribution. Similarly, the Z-score is given by:</p>
<p><span class="math display">\[
Z-Score_{d(g,t)} = \frac{d(g,t) - \mu_{d(g,t)}}{\sigma_{d(g,t)}}.
\]</span></p>
</div>
<div id="example-in-real-data-2" class="section level2" number="4.2">
<h2><span class="header-section-number">4.2</span> Example in real data</h2>
<p>Let’s try it to identify drugs that could work for our disease sets. Let’s focus on hyperlipidemia and focus on five drugs at first.</p>
<ul>
<li>Asenapine;</li>
<li>Phentermine;</li>
<li>Simvastatin;</li>
<li>Pizotifen;</li>
<li>Eprotirome.</li>
</ul>
<div class="sourceCode" id="cb54"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb54-1"><a href="method-for-drug-repurpusing.html#cb54-1" aria-hidden="true" tabindex="-1"></a>hyperlipidemia_genes <span class="ot">=</span> Cleaned_GDA <span class="sc">%&gt;%</span></span>
<span id="cb54-2"><a href="method-for-drug-repurpusing.html#cb54-2" aria-hidden="true" tabindex="-1"></a>  <span class="fu">filter</span>(diseaseName <span class="sc">==</span> <span class="st">&#39;hyperlipidemia&#39;</span>) <span class="sc">%&gt;%</span> </span>
<span id="cb54-3"><a href="method-for-drug-repurpusing.html#cb54-3" aria-hidden="true" tabindex="-1"></a>  <span class="fu">pull</span>(geneSymbol) <span class="sc">%&gt;%</span> </span>
<span id="cb54-4"><a href="method-for-drug-repurpusing.html#cb54-4" aria-hidden="true" tabindex="-1"></a>  <span class="fu">unique</span>()</span>
<span id="cb54-5"><a href="method-for-drug-repurpusing.html#cb54-5" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb54-6"><a href="method-for-drug-repurpusing.html#cb54-6" aria-hidden="true" tabindex="-1"></a>Asenapine_t <span class="ot">=</span> DT <span class="sc">%&gt;%</span> </span>
<span id="cb54-7"><a href="method-for-drug-repurpusing.html#cb54-7" aria-hidden="true" tabindex="-1"></a>  <span class="fu">filter</span>(Name <span class="sc">==</span> <span class="st">&#39;Asenapine&#39;</span>) <span class="sc">%&gt;%</span></span>
<span id="cb54-8"><a href="method-for-drug-repurpusing.html#cb54-8" aria-hidden="true" tabindex="-1"></a>  <span class="fu">pull</span>(Gene_Target)</span>
<span id="cb54-9"><a href="method-for-drug-repurpusing.html#cb54-9" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb54-10"><a href="method-for-drug-repurpusing.html#cb54-10" aria-hidden="true" tabindex="-1"></a>Asenapine_t</span></code></pre></div>
<pre><code>##  [1] &quot;HTR1A&quot;  &quot;HTR1B&quot;  &quot;HTR2A&quot;  &quot;HTR2B&quot;  &quot;HTR2C&quot;  &quot;HTR5A&quot;  &quot;HTR6&quot;   &quot;HTR7&quot;  
##  [9] &quot;DRD2&quot;   &quot;DRD3&quot;   &quot;DRD4&quot;   &quot;DRD1&quot;   &quot;ADRA1A&quot; &quot;ADRA2A&quot; &quot;ADRA2B&quot; &quot;ADRA2C&quot;
## [17] &quot;HRH1&quot;   &quot;HRH2&quot;   &quot;ADRB1&quot;  &quot;ADRB2&quot;  &quot;UGT1A4&quot; &quot;CYP1A2&quot; &quot;CYP2D6&quot; &quot;CYP3A4&quot;
## [25] &quot;ALB&quot;    &quot;ORM1&quot;</code></pre>
<div class="sourceCode" id="cb56"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb56-1"><a href="method-for-drug-repurpusing.html#cb56-1" aria-hidden="true" tabindex="-1"></a><span class="fu">proximity_average</span>(gPPI, </span>
<span id="cb56-2"><a href="method-for-drug-repurpusing.html#cb56-2" aria-hidden="true" tabindex="-1"></a>                  <span class="at">source =</span> hyperlipidemia_genes, </span>
<span id="cb56-3"><a href="method-for-drug-repurpusing.html#cb56-3" aria-hidden="true" tabindex="-1"></a>                  <span class="at">targets =</span> Asenapine_t)</span></code></pre></div>
<pre><code>## [1] 1.961538</code></pre>
<p>Let’s do it in a loop:</p>
<div class="sourceCode" id="cb58"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb58-1"><a href="method-for-drug-repurpusing.html#cb58-1" aria-hidden="true" tabindex="-1"></a>drugs <span class="ot">=</span> <span class="fu">c</span>(<span class="st">&quot;Asenapine&quot;</span>, </span>
<span id="cb58-2"><a href="method-for-drug-repurpusing.html#cb58-2" aria-hidden="true" tabindex="-1"></a>          <span class="st">&#39;Phentermine&#39;</span>, </span>
<span id="cb58-3"><a href="method-for-drug-repurpusing.html#cb58-3" aria-hidden="true" tabindex="-1"></a>          <span class="st">&#39;Simvastatin&#39;</span>, </span>
<span id="cb58-4"><a href="method-for-drug-repurpusing.html#cb58-4" aria-hidden="true" tabindex="-1"></a>          <span class="st">&#39;Pizotifen&#39;</span>,</span>
<span id="cb58-5"><a href="method-for-drug-repurpusing.html#cb58-5" aria-hidden="true" tabindex="-1"></a>          <span class="st">&#39;Eprotirome&#39;</span>)</span>
<span id="cb58-6"><a href="method-for-drug-repurpusing.html#cb58-6" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb58-7"><a href="method-for-drug-repurpusing.html#cb58-7" aria-hidden="true" tabindex="-1"></a>p <span class="ot">=</span> <span class="fu">list</span>()</span>
<span id="cb58-8"><a href="method-for-drug-repurpusing.html#cb58-8" aria-hidden="true" tabindex="-1"></a><span class="cf">for</span>(i <span class="cf">in</span> <span class="dv">1</span><span class="sc">:</span><span class="fu">length</span>(drugs)){</span>
<span id="cb58-9"><a href="method-for-drug-repurpusing.html#cb58-9" aria-hidden="true" tabindex="-1"></a>  d <span class="ot">=</span> drugs[i]</span>
<span id="cb58-10"><a href="method-for-drug-repurpusing.html#cb58-10" aria-hidden="true" tabindex="-1"></a>  Drug_targets <span class="ot">=</span> DT <span class="sc">%&gt;%</span> </span>
<span id="cb58-11"><a href="method-for-drug-repurpusing.html#cb58-11" aria-hidden="true" tabindex="-1"></a>    <span class="fu">filter</span>(Name <span class="sc">%in%</span> d) <span class="sc">%&gt;%</span></span>
<span id="cb58-12"><a href="method-for-drug-repurpusing.html#cb58-12" aria-hidden="true" tabindex="-1"></a>    <span class="fu">pull</span>(Gene_Target)</span>
<span id="cb58-13"><a href="method-for-drug-repurpusing.html#cb58-13" aria-hidden="true" tabindex="-1"></a>  </span>
<span id="cb58-14"><a href="method-for-drug-repurpusing.html#cb58-14" aria-hidden="true" tabindex="-1"></a>  prox <span class="ot">=</span> <span class="fu">proximity_average</span>(gPPI, </span>
<span id="cb58-15"><a href="method-for-drug-repurpusing.html#cb58-15" aria-hidden="true" tabindex="-1"></a>                           <span class="at">source =</span> hyperlipidemia_genes, </span>
<span id="cb58-16"><a href="method-for-drug-repurpusing.html#cb58-16" aria-hidden="true" tabindex="-1"></a>                           <span class="at">targets =</span> Drug_targets)</span>
<span id="cb58-17"><a href="method-for-drug-repurpusing.html#cb58-17" aria-hidden="true" tabindex="-1"></a>  </span>
<span id="cb58-18"><a href="method-for-drug-repurpusing.html#cb58-18" aria-hidden="true" tabindex="-1"></a>  p[[i]] <span class="ot">=</span> <span class="fu">data.frame</span>(<span class="at">prox =</span> prox, </span>
<span id="cb58-19"><a href="method-for-drug-repurpusing.html#cb58-19" aria-hidden="true" tabindex="-1"></a>                      <span class="at">ntargets =</span> <span class="fu">length</span>(Drug_targets), </span>
<span id="cb58-20"><a href="method-for-drug-repurpusing.html#cb58-20" aria-hidden="true" tabindex="-1"></a>                      <span class="at">drug =</span> d)</span>
<span id="cb58-21"><a href="method-for-drug-repurpusing.html#cb58-21" aria-hidden="true" tabindex="-1"></a>}</span>
<span id="cb58-22"><a href="method-for-drug-repurpusing.html#cb58-22" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb58-23"><a href="method-for-drug-repurpusing.html#cb58-23" aria-hidden="true" tabindex="-1"></a>p <span class="sc">%&lt;&gt;%</span> <span class="fu">bind_rows</span>()</span></code></pre></div>
<p>Now, let’s do the same, but also calculating the significance of the proximity.</p>
<div class="sourceCode" id="cb59"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb59-1"><a href="method-for-drug-repurpusing.html#cb59-1" aria-hidden="true" tabindex="-1"></a>Drug_Target <span class="ot">=</span> DT <span class="sc">%&gt;%</span> </span>
<span id="cb59-2"><a href="method-for-drug-repurpusing.html#cb59-2" aria-hidden="true" tabindex="-1"></a>  <span class="fu">filter</span>(Name <span class="sc">%in%</span> drugs) <span class="sc">%&gt;%</span> </span>
<span id="cb59-3"><a href="method-for-drug-repurpusing.html#cb59-3" aria-hidden="true" tabindex="-1"></a>  <span class="fu">select</span>(Name, Gene_Target) <span class="sc">%&gt;%</span> </span>
<span id="cb59-4"><a href="method-for-drug-repurpusing.html#cb59-4" aria-hidden="true" tabindex="-1"></a>  <span class="fu">unique</span>()</span>
<span id="cb59-5"><a href="method-for-drug-repurpusing.html#cb59-5" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb59-6"><a href="method-for-drug-repurpusing.html#cb59-6" aria-hidden="true" tabindex="-1"></a><span class="fu">names</span>(Drug_Target) <span class="ot">=</span> <span class="fu">c</span>(<span class="st">&#39;ID&#39;</span>, <span class="st">&quot;Target&quot;</span> )</span>
<span id="cb59-7"><a href="method-for-drug-repurpusing.html#cb59-7" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb59-8"><a href="method-for-drug-repurpusing.html#cb59-8" aria-hidden="true" tabindex="-1"></a>proximity_significance <span class="ot">=</span> <span class="fu">avr_proximity_multiple_target_sets</span>(</span>
<span id="cb59-9"><a href="method-for-drug-repurpusing.html#cb59-9" aria-hidden="true" tabindex="-1"></a>  <span class="at">set =</span> drugs,</span>
<span id="cb59-10"><a href="method-for-drug-repurpusing.html#cb59-10" aria-hidden="true" tabindex="-1"></a>  <span class="at">G =</span> gPPI,</span>
<span id="cb59-11"><a href="method-for-drug-repurpusing.html#cb59-11" aria-hidden="true" tabindex="-1"></a>  <span class="at">ST =</span> Drug_Target,</span>
<span id="cb59-12"><a href="method-for-drug-repurpusing.html#cb59-12" aria-hidden="true" tabindex="-1"></a>  <span class="at">source =</span> hyperlipidemia_genes,</span>
<span id="cb59-13"><a href="method-for-drug-repurpusing.html#cb59-13" aria-hidden="true" tabindex="-1"></a>  <span class="at">N =</span> <span class="dv">10</span>,</span>
<span id="cb59-14"><a href="method-for-drug-repurpusing.html#cb59-14" aria-hidden="true" tabindex="-1"></a>  <span class="at">bins =</span> <span class="dv">100</span>,</span>
<span id="cb59-15"><a href="method-for-drug-repurpusing.html#cb59-15" aria-hidden="true" tabindex="-1"></a>  <span class="at">min_per_bin =</span> <span class="dv">20</span></span>
<span id="cb59-16"><a href="method-for-drug-repurpusing.html#cb59-16" aria-hidden="true" tabindex="-1"></a>)</span></code></pre></div>
<pre><code>## 
  |                                                                            
  |                                                                      |   0%
  |                                                                            
  |==============                                                        |  20%
  |                                                                            
  |============================                                          |  40%
  |                                                                            
  |==========================================                            |  60%
  |                                                                            
  |========================================================              |  80%
  |                                                                            
  |======================================================================| 100%</code></pre>
<p>Which are the drugs that we can use for hyperlipidemia?</p>
<div class="sourceCode" id="cb61"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb61-1"><a href="method-for-drug-repurpusing.html#cb61-1" aria-hidden="true" tabindex="-1"></a>proximity_significance</span></code></pre></div>
<pre><code>##                    Drug targets targets_G proximity  IC_97.5   IC_2.5 p_gt p_lt
## Asenapine     Asenapine      26        26  1.961538 2.251923 1.978846  0.9  0.1
## Phentermine Phentermine       7         7  2.000000 2.792857 2.142857  1.0  0.0
## Simvastatin Simvastatin      20        19  2.157895 2.619737 2.327632  1.0  0.0
## Pizotifen     Pizotifen      17        17  2.058824 2.294118 1.876471  0.7  0.3
## Eprotirome   Eprotirome       2         2  1.500000 2.000000 2.000000  1.0  0.0
##                      Z
## Asenapine   -1.7084389
## Phentermine -1.8973666
## Simvastatin -2.8460499
## Pizotifen   -0.5217939
## Eprotirome        -Inf</code></pre>
<p>Now, let us check those drug indications:</p>
<div class="sourceCode" id="cb63"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb63-1"><a href="method-for-drug-repurpusing.html#cb63-1" aria-hidden="true" tabindex="-1"></a>Indication <span class="ot">=</span> DT <span class="sc">%&gt;%</span> </span>
<span id="cb63-2"><a href="method-for-drug-repurpusing.html#cb63-2" aria-hidden="true" tabindex="-1"></a>  <span class="fu">filter</span>(Name <span class="sc">%in%</span> drugs) <span class="sc">%&gt;%</span> </span>
<span id="cb63-3"><a href="method-for-drug-repurpusing.html#cb63-3" aria-hidden="true" tabindex="-1"></a>  <span class="fu">select</span>(Name, Indication) <span class="sc">%&gt;%</span> </span>
<span id="cb63-4"><a href="method-for-drug-repurpusing.html#cb63-4" aria-hidden="true" tabindex="-1"></a>  <span class="fu">unique</span>()</span>
<span id="cb63-5"><a href="method-for-drug-repurpusing.html#cb63-5" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb63-6"><a href="method-for-drug-repurpusing.html#cb63-6" aria-hidden="true" tabindex="-1"></a>Indication</span></code></pre></div>
<pre><code>##           Name
## 1: Phentermine
## 2: Simvastatin
## 3:  Eprotirome
## 4:   Pizotifen
## 5:   Asenapine
##                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Indication
## 1:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Phentermine is indicated, alone or in combination with topiramate, as a short-term adjunct, not pass a few weeks, in a regimen of weight reduction based on exercise, behavioral modifications and caloric restriction in the management of exogenous obesity for patients with an initial body mass index (BMI) greater than 30 kg/m2 or greater than 27 kg/m2 in presence of other risk factors such as controller hypertension, diabetes or hyperlipidemia.[FDA label]\r\n\r\nExogenous obesity is considered when the overweight is caused by consuming more food than the person activity level warrants. This condition commonly causes an increase in fat storage. It is an epidemic condition in the United States where over two-thirds of adults are overweight or obese and one in three Americans is obese. In the world, the incidence of obesity has nearly doubled.[A174391]
## 2: Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDL‑C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).[F4655, F4658]\r\n\r\nThis includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH).[F4655, F4658]\r\n\r\nSimvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease.[F4655, F4658]\r\n\r\nPrescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]
## 3:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Investigated for use/treatment in hyperlipidemia, metabolic disease, and obesity.
## 4:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Indicated for the prophylactic management of migraines [L2292].
## 5:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Used for treatment in psychosis, schizophrenia and schizoaffective disorders, manic disorders, and bipolar disorders as monotherapy or in combination.</code></pre>
</div>
<div id="exercises-5" class="section level2" number="4.3">
<h2><span class="header-section-number">4.3</span> Exercises</h2>
<ol style="list-style-type: decimal">
<li><p>Test the same drugs for all the five other diseases we are interested. How do those values compare?</p>
<ul>
<li>Autistic Disorder;</li>
<li>Obesity;</li>
<li>Hyperlipidemia;</li>
<li>Rheumatoid Arthritis.</li>
</ul></li>
<li><p>Choose one disease and visualize the disease module along with each of the drugs we tested.</p></li>
</ol>

</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="methods.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="summary.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["NetMed.pdf", "NetMed.epub"],
"toc": {
"collapse": "subsection"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
